Log in
Show password
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 
News: Latest News
Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors

Olympus Stem Cells Demonstrates Hair Regeneration with Stem Cells and Zinc for Patients with Alopecia

03/14/2018 | 12:48pm EST

SYDNEY, AUSTRALIA / ACCESSWIRE / March 14, 2018 / Medical clinic and research facility Olympus Stem Cells Pty Ltd, based in Sydney Olympic Park, NSW, Australia, are pleased to announce cutting edge hair regenerative treatment with stem cell scalp injections and the use of a patented formula of Zinc Thymulin to regenerate hair lost as a result of Androgenic Alopecia.

More details can be obtained from http://www.olympusstemcells.com.au and http://www.clinicalstemcells.com.

The Director of Olympus Stem Cells, Associate Professor Russell Vickers, is an acknowledged world authority in the use of stem cells to treat neuropathic pain, dry eyes (keratoconjunctivitis sicca), dry mouth (xerostomia), symptoms of MS related to facial pain, osteoarthritis of and the Temporomandibular joint. Professor Vickers has discovered the use of a Zinc extract (in this case Zinc Thymulin used as a topical solution) and combined with stem cells to regenerate hair lost as a result of androgenic alopecia. He is pleased to offer stem cell services including consultations and treatment amongst the 5 medical centres in Sydney Australia. Associate Professor Russell Vickers, has published extensively on the use of stem cells in neuropathic facial pain, stem cell protocols and is a leader in his field. He is conducting clinical treatment of Alopecia patients with stem cells harvested from the abdomen. The results so far have been outstanding and published in the peer reviewed Hair Restoration journal, Hair Therapy and Transplantation (see references).

Associate Professor Vickers sources the abdominal fat for adipose derived stem cells. He processes the fat and obtains stem cell concentrations that are extremely generous in numbers and quality. As a consultant surgeon he then delivers the stem cells to the anatomical area requiring the specific treatment, in this case the area of hair loss. The stem cells are injected supragaleal.

Associate Professor Vickers utilises a vast array of medical scientific equipment in his quest to offer the very best of stem cell treatment. For validation he uses the Muse Cell Analyser and is achieving 100% of stem cell viability. Additionally Olympus Stem Cells Pty Ltd has the availability of its own Mass Spectrometer and cell counting technology. In many conditions Stem Cell Therapy is a highly effective means of alleviating pain and discomfort for people suffering a variety of conditions ranging from MS to neuropathic facial pain. Associate Professor Vickers has published in peer reviewed journals the efficacy of his treatment. We are proud to be one of Sydney's best Stem Cell and Hair loss providers, with a proven track record of providing safe, effective treatment and expert care for our patients. Olympus has a strong focus on research and development and is working hard to constantly further the advancement of stem cell techniques around the world. Our research has been published internationally in peer-reviewed medical and science journals, plus our laboratory boasts some of the best state-of-the-art biotechnology equipment in Australia.

Olympus Stem Cells Pty Ltd is one of the few companies undertaking ground breaking stem cell treatment in Australia and the Asia-Pacific region.

More information on the Olympus clinics and the work that they do can be obtained at http://www.olympushealthgroup.com.au.

Associate Professor Vickers' recent research publications pertaining to genetics, stem cells, hair loss and facial pain are extensive. These publications include Human Brain Mapping, the Australian Endodontic Journal, Hair Therapy and Transplantation, The Journal of Neuroscience, Diagnosing Dental and Orofacial Pain, the Journal of the Australian Society of Cosmetic Chemists, Medicine Today (The Journal of the Royal Australian College of General Practitioners), the Open Journal of Dentistry and Oral Medicine, and the Journal of Pain Research. More information on Associate Professor Vickers' work can be obtained at http://www.clinicalstemcells.com.

Contact Olympus Stem Cells Pty Ltd:

Professor Russell Vickers
+61 4277 11 888
Olympus Stem Cell Centre, Sydney Olympic Park, 5 Australia Avenue, Sydney Olympic Park, NSW, Australia

SOURCE: Olympus Stem Cells Pty Ltd.

ę Accesswire 2018
Latest news "Companies"
08:36aThinking about buying stock in Airsculpt Technologies, Cidara Therapeutics, Fastly, UiPath, or Renew Energy Global?
08:35aMMG's Las Bambas mine in Peru faces new shutdown as talks to end blockade fail
08:35aCompany Announcement 15 / 2021 - De-listing from OTCQX
08:35aIBU-TEC ADVANCED MATERIALS AG : Jörg Leinenbach prolongs Executive Board contract and becomes Co-CEO
08:34aForm 8 (OPD) Invesco Ltd. Form 8.3 Clinigen Group Plc
08:34aCEO & Founder of Evolution Academy Charter School District Elected to Texas Public Charter School Association Board of Directors
08:33aShiftPixy, Inc. Reports Fiscal 2021 Results
08:32aPUBLIC JOINT STOCK GAZPROM : Alexey Miller and Milorad Dodik, member of Bosnia and Herzegovina's Presidency, discuss supplies of Russian gas
08:32aPUBLIC JOINT STOCK GAZPROM : 25th anniversary General Meeting of International Business Congress to be held in St. Petersburg on June 3, 2022
08:32aSAP : Helping to Close the Computer Science Education Disparity
Latest news "Companies"